Furthermore, increased DUSP4 expression levels in CRC demonstrate a significant association with distant metastasis and poor clinical outcomes, suggesting the oncogenic activity of DUSP4 in CRC. This evidence concerns the gene DUSP4 and colorectal carcinoma.